LifeMD Price to Book Ratio 2011-2025 | LFMD
Historical price to book ratio values for LifeMD (LFMD) over the last 10 years. The current price to book ratio for LifeMD as of June 24, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| LifeMD Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-06-25 | 12.84 | 0.00 | |
| 2025-03-31 | 5.44 | $-0.01 | -604.44 |
| 2024-12-31 | 4.95 | $-0.10 | -51.62 |
| 2024-09-30 | 5.24 | $-0.14 | -36.80 |
| 2024-06-30 | 6.86 | $-0.05 | -138.87 |
| 2024-03-31 | 10.28 | $0.03 | 321.25 |
| 2023-12-31 | 8.29 | $0.15 | 56.98 |
| 2023-09-30 | 6.25 | $-0.32 | -19.54 |
| 2023-06-30 | 4.35 | $-0.31 | -13.84 |
| 2023-03-31 | 1.70 | $-0.23 | -7.38 |
| 2022-12-31 | 1.94 | $-0.23 | -8.35 |
| 2022-09-30 | 1.97 | $0.10 | 20.04 |
| 2022-06-30 | 2.04 | $0.22 | 9.25 |
| 2022-03-31 | 3.53 | $0.53 | 6.65 |
| 2021-12-31 | 3.87 | $0.84 | 4.59 |
| 2021-09-30 | 6.21 | $-0.55 | -11.33 |
| 2021-06-30 | 11.78 | $-0.30 | -38.90 |
| 2021-03-31 | 15.82 | $-0.03 | -485.28 |
| 2020-12-31 | 6.53 | $-0.04 | -185.51 |
| 2020-09-30 | 8.25 | $-0.51 | -16.09 |
| 2020-06-30 | 1.50 | $-0.35 | -4.34 |
| 2020-03-31 | 1.05 | $-0.35 | -3.04 |
| 2019-12-31 | 0.60 | $-0.11 | -5.62 |
| 2019-09-30 | 0.85 | $-0.05 | -15.83 |
| 2019-06-30 | 0.55 | $-0.15 | -3.57 |
| 2019-03-31 | 0.75 | $0.02 | 31.25 |
| 2018-12-31 | 0.70 | $0.09 | 7.73 |
| 2018-09-30 | 1.00 | $0.13 | 7.47 |
| 2018-06-30 | 1.10 | $0.15 | 7.20 |
| 2018-03-31 | 1.40 | $0.10 | 13.73 |
| 2017-12-31 | 1.70 | $0.07 | 24.01 |
| 2017-09-30 | 2.15 | $0.06 | 33.54 |
| 2017-06-30 | 1.50 | $-0.05 | -28.14 |
| 2017-03-31 | 2.50 | $-0.16 | -15.19 |
| 2016-12-31 | 1.30 | $-0.05 | -25.34 |
| 2016-09-30 | 1.30 | $0.07 | 19.73 |
| 2016-06-30 | 1.30 | $0.05 | 25.90 |
| 2016-03-31 | 1.50 | $0.03 | 47.02 |
| 2015-12-31 | 0.60 | $0.03 | 21.20 |
| 2015-09-30 | 0.25 | $-0.02 | -11.21 |
| 2015-06-30 | 0.45 | $-0.03 | -16.61 |
| 2015-03-31 | 0.90 | $-0.02 | -40.72 |
| 2014-12-31 | 0.50 | $-0.02 | -22.03 |
| 2014-09-30 | 0.65 | $0.00 | -132.65 |
| 2014-06-30 | 0.70 | $0.00 | 291.67 |
| 2014-03-31 | 1.25 | $0.01 | 91.24 |
| 2013-12-31 | 1.30 | $0.03 | 40.00 |
| 2013-09-30 | 1.30 | $0.01 | 188.41 |
| 2013-06-30 | 1.45 | $0.03 | 47.39 |
| 2013-03-31 | 0.65 | $0.02 | 31.25 |
| 2012-12-31 | 0.80 | $0.02 | 34.33 |
| 2012-09-30 | 0.90 | 0.00 | |
| 2012-06-30 | 0.80 | 0.00 | |
| 2012-03-31 | 0.90 | 0.00 | |
| 2011-12-31 | 1.00 | 0.00 | |
| 2010-12-31 | 1.25 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.639B | $0.212B |
| LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers. LifeMD Inc., formerly known as Conversion Labs, is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $141.323B | 26.51 |
| CVS Health (CVS) | United States | $85.490B | 10.63 |
| Elevance Health (ELV) | United States | $85.046B | 10.97 |
| Cencora (COR) | United States | $57.007B | 19.83 |
| Natera (NTRA) | United States | $23.468B | 0.00 |
| DiDi Global (DIDIY) | China | $23.015B | 24.45 |
| Labcorp Holdings (LH) | United States | $21.974B | 17.82 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.262B | 0.00 |
| Solventum (SOLV) | United States | $12.973B | 13.73 |
| CochLear (CHEOY) | Australia | $12.633B | 0.00 |
| ICON (ICLR) | Ireland | $11.996B | 11.15 |
| Revvity (RVTY) | United States | $11.361B | 19.55 |
| Viatris (VTRS) | United States | $10.504B | 3.61 |
| Avantor (AVTR) | United States | $9.172B | 13.33 |
| Medpace Holdings (MEDP) | United States | $9.062B | 24.07 |
| HealthEquity (HQY) | United States | $9.009B | 39.46 |
| Sonic Healthcare (SKHHY) | Australia | $8.263B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.289B | 14.28 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.259B | 25.08 |
| BrightSpring Health Services (BTSG) | United States | $4.024B | 36.92 |
| Sotera Health (SHC) | United States | $3.191B | 18.13 |
| Alignment Healthcare (ALHC) | United States | $2.786B | 0.00 |
| Concentras Parent (CON) | United States | $2.716B | 15.70 |
| Surgery Partners (SGRY) | United States | $2.705B | 35.18 |
| GeneDx Holdings (WGS) | United States | $2.594B | 99.89 |
| Organon (OGN) | United States | $2.587B | 2.75 |
| PACS (PACS) | United States | $1.928B | 0.00 |
| Ardent Health (ARDT) | United States | $1.887B | 8.04 |
| Progyny (PGNY) | United States | $1.822B | 40.11 |
| GoodRx Holdings (GDRX) | United States | $1.811B | 36.21 |
| Premier (PINC) | United States | $1.791B | 13.59 |
| Teladoc Health (TDOC) | United States | $1.403B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.158B | 8.81 |
| CareDx (CDNA) | United States | $1.051B | 16.42 |
| Establishment Labs Holdings (ESTA) | $1.034B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.999B | 0.00 |
| Agilon Health (AGL) | United States | $0.915B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.831B | 7.78 |
| Nutex Health (NUTX) | United States | $0.641B | 9.70 |
| Embecta (EMBC) | United States | $0.597B | 4.02 |
| InnovAge Holding (INNV) | United States | $0.545B | 0.00 |
| Enhabit (EHAB) | United States | $0.482B | 39.62 |
| Sonida Senior Living (SNDA) | United States | $0.463B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.463B | 10.42 |
| SBC Medicals (SBC) | United States | $0.442B | 0.00 |
| Omada Health (OMDA) | $0.404B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.298B | 0.00 |
| Beauty Health (SKIN) | United States | $0.242B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.237B | 0.00 |
| Oncology Institute (TOI) | United States | $0.210B | 0.00 |
| DocGo (DCGO) | United States | $0.176B | 28.83 |
| So-Young (SY) | China | $0.174B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.123B | 0.00 |
| OncoCyte (IMDX) | United States | $0.099B | 0.00 |
| KindlyMD (NAKA) | United States | $0.092B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.076B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
| ModivCare (MODV) | United States | $0.046B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.041B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |